08/15/2025
🇺🇦 Yesterday in Kyiv, leaders from across Ukraine’s health sector, government, civil society, and international partners gathered for a milestone event marking eight years of impact from the Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) project, implemented by Management Sciences for Health with support from the U.S. Government.
Since 2017, has worked with Ukrainian partners to transform the country’s pharmaceutical system — making medicines more affordable, strengthening supply chains, and embedding transparency in procurement.
These and other results speak for themselves:
✔️ 5.6M patients reached through the Affordable Medicines program, with more than 15,000 pharmacies enrolled nationwide
✔️ UAH 9.2B (~$259M USD) in national budget savings through procurement reforms
✔️ 12,800+ tons of humanitarian aid worth over UAH 20.5B (~$500M USD) delivered during the first years of the full-scale invasion.
✔️ Expanded access to HIV, tuberculosis, and hepatitis treatment, even in frontline communities.
High-level government representatives recognized the program’s real impact on the lives of millions of Ukrainians — even amid war.
Closing the event, MSH Chief Operating Officer Deborah Hutchison reflected on the lasting value of these reforms: “When the war began, the same systems we had built together proved adaptable and indispensable… Investments that keep delivering impact far beyond their original scope.”
This milestone is a testament to what strong systems make possible — saving lives, protecting transparency, and ensuring access to medicines now and into the future.
📄 Learn more about the systems, innovations, and partnerships driving this change:https://msh.org/wp-content/uploads/2025/08/SAFEMed-Leaflet.pdf
💬 Read patient and partner voices: https://msh.org/story/eight-years-of-driving-change/
📸 Photographer: Oleksandr Tsybin